icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Effect of Long-Term Viral Suppression With Sofosbuvir + Ribavirin on Hepatic
Venous Pressure Gradient in HCV-Infected Patients With Cirrhosis and Portal Hypertension

 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Nezam Afdhal,1 Gregory T. Everson,2 Jose Luis Calleja,3 Geoffrey McCaughan,4 Jaime Bosch,5 Jill Denning,6 Diana M. Brainard,6 John G. McHutchison,6 Theo Brandt-Sarif,6 Di An,6 Michael Charlton,7 K. Rajender Reddy,8 Tarik Asselah,9 Edward Gane,10 Xavier Forns5
1Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; 2University of Colorado Denver, Aurora, Colorado, USA; 3Hospital Puerta de Hierro, Madrid, Spain; 4Royal Prince Alfred Hospital, University of Sydney, New South Wales, Australia; 5Liver Unit, IDIBAPS, CIBEREHD, Barcelona, Spain; 6Gilead Sciences, Inc., Foster City, California, USA; 7Intermountain Medical Center, Murray, Utah, USA; 8University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, 9Hopital Beaujon, INSERM U773 and University Paris-Diderot, Clichy, France; 10University of Auckland, New Zealand

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif